Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials

Authors: Olivia R. Ghosh‐Swaby, Shaun G. Goodman, Lawrence A. Leiter, Alice Cheng, Kim A. Connelly, David Fitchett, Peter Jüni, Michael E. Farkouh, Jacob A. Udell - The Lancet 2020 cited by 166